Crisprmedicinenews FZD6 Targeting Identified as Key for Advanced Prostate Cancer Treatment
Article Content
Browse articles 
Researchers have identified FZD6 as a critical therapeutic target in advanced prostate cancer, revealing that its inhibition sensitizes cancer cells to specific kinase inhibitors. This discovery comes amid challenges associated with pan-Wnt signaling, which can lead to dose-limiting toxicities in patients. The findings suggest that targeting FZD6 may provide a more selective and effective treatment strategy.
Ask AI about this cluster
Answers cite the sources they use
Updated 213d ago How this analysis works
More articles in this cluster (2)
Continue Reading
CVE-2015-3306 Exploited in ProFTPD FTP Servers CVE-2015-3306, a vulnerability in ProFTPD 1.3.5, allows remote attackers to read and write arbitrary files using the SITE CPFR and SITE CPTO commands. This exploit can lead to unauthorized access and potential remote code execution, as the commands are executed with the privileges of the ProFTPD service. Active… 
CISA Mandates Urgent Patching of Five Critical Flaws Exploited by Flax Typhoon The U.S. Cybersecurity and Infrastructure Security Agency (CISA) has ordered federal agencies to patch five critical vulnerabilities by October 11, 2026, following exploitation by the China-linked hacking group Flax Typhoon. The vulnerabilities, added to CISA's Known Exploited Vulnerabilities (KEV) catalog, include…